|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
2 months to Dec 31, 2018
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Gain on marketable securities (net), and dividends held in Trust Account | ||||
| Net income (loss) | ||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||
| Depreciation and amortization | ||||
| Amortization of investment premium paid | ||||
| Stock-based compensation | ||||
| Inventory provision | ||||
| Change in fair value of public and private placement warrants | ||||
| Gain from extinguishment of PPP loans | ||||
| Interest expense attributable to amortization of debt discount | ||||
| Conversion of promissory notes and accrued interest to common stock | ||||
| Allocation of debt proceeds to beneficial conversion feature | ||||
| Allocation of debt proceeds to stock warrants | ||||
| Exercise of warrants in exchange for note receivable | ||||
| Investment in Joint Venture | ||||
| Reverse recapitalization effect on additional paid-in capital | ||||
| Transaction costs included in accounts payable and accrued expenses | ||||
| Loss in equity method investments | ||||
| Non-cash lease expense-operating leases | ||||
| Non-cash lease expense - operating leases | ||||
| Non-cash lease expense - finance leases | ||||
| Loss on extinguishment of stockholder note receivable | ||||
| Other | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Inventories | ||||
| Prepaid expenses | ||||
| Franchise tax payable | ||||
| Income tax payable | ||||
| Prepaid inventories | ||||
| Prepaid and other current assets | ||||
| Prepayment - long-term supply agreement | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Interest accrued on notes payable | ||||
| Deferred costs | ||||
| Contract liabilities | ||||
| Operating lease liabilities | ||||
| Other, net | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchase of marketable securities held in Trust Account | ||||
| Proceeds received from sales, redemptions and maturities of marketable securities held in Trust Account | ||||
| Purchase of investments | ||||
| Proceeds from maturities of investments | ||||
| Proceeds from sales of investments | ||||
| Equity method investment | ||||
| Other-net | ||||
| Capital expenditures | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds received under loans from related parties | ||||
| Repayment of amounts due to related parties | ||||
| Issuance of convertible notes | ||||
| Issuance of term notes | ||||
| Proceeds from PPP loan | ||||
| Proceeds from stockholder note receivable | ||||
| Repayment of term and convertible notes | ||||
| Issuance of line of credit | ||||
| Repayment of line of credit | ||||
| Redemption of common stock | ||||
| Recapitalization transaction, net of transaction costs | ||||
| Issuance of common stock, net of issuance costs | ||||
| Anchor Investors | ||||
| Total issuance of common stock, net of issuance costs | ||||
| Proceeds received from initial public offering, gross | ||||
| Proceeds received from private placement | ||||
| Offering costs paid | ||||
| Exercise of stock options | ||||
| Exercise of stock warrants | ||||
| Payment for financed capital expenditures | ||||
| Settlement on restricted stock tax withholding | ||||
| Warrant redemption payments | ||||
| Principal portion of finance lease liabilities | ||||
| Rescission of common stock | ||||
| Net cash provided by financing activities | ||||
| Net change in cash, cash equivalents and restricted cash | ||||
| Cash and cash equivalents | ||||
| Cash, cash equivalents and restricted cash, beginning of period | ||||
| Cash, cash equivalents and restricted cash, end of period | ||||
| Supplemental cash flow information: | ||||
| Cash paid for interest | ||||
| Cash paid for income taxes | ||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||
| Operating lease right-of-use assets obtained in exchange of operating lease liabilities | ||||
| Finance lease right-of-use assets obtained in exchange of finance lease liabilities | ||||
| Purchases of property, plant and equipment in accounts payable and accrued expenses at the end of period | ||||
| Issuance of common stock as contract consideration | ||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | ||||
| Cash and cash equivalents | ||||
| Offering costs included in accrued expenses | ||||
| Forfeiture of Class B common stock from Sponsor | ||||
| Deferred underwriting commissions in connection with the initial public offering | ||||
| Deferred legal fees in connection with the initial public offering | ||||
| Reclassification of deferred offering costs to equity upon completion of the initial public offering | ||||
| Restricted cash | ||||
Loading...